Dipeptidylpeptidase-­IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats

Submitted: 21 December 2011
Accepted: 26 July 2012
Published: 8 October 2012
Abstract Views: 1015
PDF: 573
HTML: 1078
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Given the scarcity of donors, moderately fatty livers (FLs) are currently being considered as possible grafts for orthotopic liver transplantation (OLT), notwithstanding their poor tolerance to conventional cold preservation. The behaviour of parenchymal and sinusoidal liver cells during transplantation is being studied worldwide. Much less attention has been paid to the biliary tree, although this is considered the Achille’s heel even of normal liver transplantation. To evaluate the response of the biliary compartment of FLs to the various phases of OLT reliable markers are necessary. Previously we demonstrated that Alkaline Phosphatase was scarcely active in bile canaliculi of FLs and thus ruled it out as a marker. As an alternative, dipeptidylpeptidase-IV (DPP-IV), was investigated. This ecto-peptidase plays an important role in glucose metabolism, rapidly inactivating insulin secreting hormones (incretins) that are important regulators of glucose metabolism. DPP-IV inhibitors are indeed used to treat Type II diabetes. Neuropeptides regulating bile transport and composition are further important substrates of DPP-IV in the enterohepatic axis. DPP-IV activity was investigated with an azo-coupling method in the liver of fatty Zucker rats (fa/fa), using as controls lean Zucker (fa/+) and normal Wistar rats. Protein expression was studied by immunofluorescence with the monoclonal antibody (clone 5E8). In Wistar rat liver, DPP-IV activity and expression were high in the whole biliary tree, and moderate in sinusoid endothelial cells, in agreement with the literature. Main substrates of DPP-IV in hepatocytes and cholangiocytes could be incretins GLP-1 and GIP, and neuropeptides such as vasoactive intestinal peptide (VIP) and substance P, suggesting that these substances are inactivated or modified through the biliary route. In lean Zucker rat liver the enzyme reaction and protein expression patterns were similar to those of Wistar rat. In obese rat liver the patterns of DPP-IV activity and expression in hepatocytes reflected the morphological alterations induced by steatosis as lipid-rich hepatocytes had scarce activity, located either in deformed bile canaliculi or in the sinusoidal and lateral domains of the plasma membrane. These findings suggest that bile canaliculi in steatotic cells have an impaired capacity to inactivate incretins and neuropeptides. Incretin and/or neuropeptide deregulation is indeed thought to play important roles in obesity and insulin-resistance. No alteration in enzyme activity and expression was found in the upper segments of the biliary tree of obese respect to lean Zucker and Wistar rats. In conclusion, this research demonstrates that DPP-IV is a promising in situ marker of biliary functionality not only of normal but also of fatty rats. The approach, initially devised to investigate the behaviour of the liver during the various phases of transplantation, appears to have a much higher potentiality as it could be further exploited to investigate any pathological or stressful conditions involving the biliary tract (i.e., metabolic syndrome and cholestasis) and the response of the biliary tract to therapy and/or to surgery.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

MIUR-PRIN (Ministero dell’Università e Ricerca, Progetti di Rilevante Interesse Nazionale) 2004 and 2006 and by F.A.R. (Fondi di Ateneo per la Ricerca), University of Pavia.
E. Tarantola, University of Pavia
Department of Biology and Biotechnology "Lazzaro Spallanzani"
V. Bertone, University of Pavia
Department of Biology and Biotechnology "Lazzaro Spallanzani"
G. Milanesi, University of Pavia
Department of Biology and Biotechnology "Lazzaro Spallanzani"
E. Capelli, University of Pavia
Department of Sciences and Technologies for the Environment
A. Ferrigno, University of Pavia
Department of Internal Medicine and Therapeutics
D. Neri, University of Padua
Surgical and Gastroenterological Department, Hepatobiliary Surgery and Liver Transplant Unit
M. Vairetti, University of Pavia
Department of Internal Medicine and Therapeutics
S. Barni, University of Pavia
Department of Biology and Biotechnology "Lazzaro Spallanzani"
I. Freitas, University of Pavia
Department of Biology and Biotechnology "Lazzaro Spallanzani" and Institute of Molecular Genetics of CNR, Histochemistry and Cytometry Section, Pavia.

How to Cite

Tarantola, E., Bertone, V., Milanesi, G., Capelli, E., Ferrigno, A., Neri, D., Vairetti, M., Barni, S., & Freitas, I. (2012). Dipeptidylpeptidase-­IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats. European Journal of Histochemistry, 56(4), e41. https://doi.org/10.4081/ejh.2012.e41